XML 63 R35.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value Measurements (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended 12 Months Ended 12 Months Ended
Mar. 31, 2013
Sep. 30, 2013
Dec. 31, 2012
Sep. 30, 2013
Interest Rate Cap [Member]
derivative_instruments
Dec. 31, 2012
Interest Rate Cap [Member]
derivative_instruments
Sep. 30, 2013
Interest Rate Swap [Member]
derivative_instruments
Dec. 31, 2012
Interest Rate Swap [Member]
derivative_instruments
Sep. 30, 2013
Citadel Mall [Member]
Consolidated Revenue [Member]
Sep. 30, 2013
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
Dec. 31, 2012
Quoted Prices in Active Markets for Identical Assets (Level 1) [Member]
Sep. 30, 2013
Significant Other Observable Inputs (Level 2) [Member]
Dec. 31, 2012
Significant Other Observable Inputs (Level 2) [Member]
Sep. 30, 2013
Fair Value, Inputs, Level 3 [Member]
Dec. 31, 2012
Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                            
Derivative instruments held       1 1 4 4              
Assets:                            
Fair value of available-for-sale securities   $ 14,556 $ 27,679           $ 14,556 $ 16,556 $ 0 $ 0 $ 0 $ 11,123
Cost Method Investments, Fair Value Disclosure     2,475             0   0   2,475
Liabilities:                            
Interest rate swaps   4,417 5,805               4,417 5,805    
Long-term Debt, Fair Value   5,069,679 5,058,411                      
Mortgage and other indebtedness   4,867,717 4,745,683                      
Available-for-sale Securities, Debt Maturities, Date Oct. 01, 2028                          
Assumed Reduction In Cash Flows Used To Calculate Fair Value Of Cost Method Investment     0% to 10%                      
Assumed Capitalization Rate Range in Determining Fair Value     10% to 12%                      
Discount Rate Used To Calculate Fair Value Of Privately Held Debt And Equity Securities     20.00%                      
Concentration risk               0.60%            
Assumed Capitalization Rate Range Used To Determine Fair Value   10% to 12%                        
Holding period   10 years                        
Asset Impairment Charges   $ 585                        
Estimated sales cost   1.00%